BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 18991199)

  • 1. Rapidly progressive neurological deterioration in a child with Alpers syndrome exhibiting a previously unremarkable brain MRI.
    Brunetti-Pierri N; Selby K; O'Sullivan M; Hendson G; Truong C; Waters PJ; Wong LJ
    Neuropediatrics; 2008 Jun; 39(3):179-83. PubMed ID: 18991199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. POLG mutations and Alpers syndrome.
    Davidzon G; Mancuso M; Ferraris S; Quinzii C; Hirano M; Peters HL; Kirby D; Thorburn DR; DiMauro S
    Ann Neurol; 2005 Jun; 57(6):921-3. PubMed ID: 15929042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular diagnosis of Alpers syndrome.
    Nguyen KV; Sharief FS; Chan SS; Copeland WC; Naviaux RK
    J Hepatol; 2006 Jul; 45(1):108-16. PubMed ID: 16545482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homozygous W748S mutation in the POLG1 gene in patients with juvenile-onset Alpers syndrome and status epilepticus.
    Uusimaa J; Hinttala R; Rantala H; Päivärinta M; Herva R; Röyttä M; Soini H; Moilanen JS; Remes AM; Hassinen IE; Majamaa K
    Epilepsia; 2008 Jun; 49(6):1038-45. PubMed ID: 18294203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. POLG1 mutations associated with progressive encephalopathy in childhood.
    Kollberg G; Moslemi AR; Darin N; Nennesmo I; Bjarnadottir I; Uvebrant P; Holme E; Melberg A; Tulinius M; Oldfors A
    J Neuropathol Exp Neurol; 2006 Aug; 65(8):758-68. PubMed ID: 16896309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion.
    Naviaux RK; Nguyen KV
    Ann Neurol; 2004 May; 55(5):706-12. PubMed ID: 15122711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. POLG mutations in Alpers syndrome.
    Nguyen KV; Østergaard E; Ravn SH; Balslev T; Danielsen ER; Vardag A; McKiernan PJ; Gray G; Naviaux RK
    Neurology; 2005 Nov; 65(9):1493-5. PubMed ID: 16177225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpers syndrome with prominent white matter changes.
    Bao X; Wu Y; Wong LJ; Zhang Y; Xiong H; Chou PC; Truong CK; Jiang Y; Qin J; Yuan Y; Lin Q; Wu X
    Brain Dev; 2008 Apr; 30(4):295-300. PubMed ID: 17923349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonally expanded mitochondrial DNA mutations in epileptic individuals with mutated DNA polymerase gamma.
    Zsurka G; Baron M; Stewart JD; Kornblum C; Bös M; Sassen R; Taylor RW; Elger CE; Chinnery PF; Kunz WS
    J Neuropathol Exp Neurol; 2008 Sep; 67(9):857-66. PubMed ID: 18716558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compound heterozygous polymerase gamma gene mutation in a patient with Alpers disease.
    Cardenas JF; Amato RS
    Semin Pediatr Neurol; 2010 Mar; 17(1):62-4. PubMed ID: 20434700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of oligonucleotide array CGH in the detection of a large intragenic deletion in POLG associated with Alpers Syndrome.
    Compton AG; Troedson C; Wilson M; Procopis PG; Li FY; Brundage EK; Yamazaki T; Thorburn DR; Wong LJ
    Mitochondrion; 2011 Jan; 11(1):104-7. PubMed ID: 20708716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. POLG mutations associated with Alpers syndrome and mitochondrial DNA depletion.
    Naviaux RK; Nguyen KV
    Ann Neurol; 2005 Sep; 58(3):491. PubMed ID: 16130100
    [No Abstract]   [Full Text] [Related]  

  • 13. Consequences of mutations in human DNA polymerase gamma.
    Longley MJ; Graziewicz MA; Bienstock RJ; Copeland WC
    Gene; 2005 Jul; 354():125-31. PubMed ID: 15913923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Status epilepticus in children with Alpers' disease caused by POLG1 mutations: EEG and MRI features.
    Wolf NI; Rahman S; Schmitt B; Taanman JW; Duncan AJ; Harting I; Wohlrab G; Ebinger F; Rating D; Bast T
    Epilepsia; 2009 Jun; 50(6):1596-607. PubMed ID: 19054397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Juvenile Alpers disease.
    Wiltshire E; Davidzon G; DiMauro S; Akman HO; Sadleir L; Haas L; Zuccollo J; McEwen A; Thorburn DR
    Arch Neurol; 2008 Jan; 65(1):121-4. PubMed ID: 18195149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic and genotypic variability in Alpers syndrome.
    Sofou K; Moslemi AR; Kollberg G; Bjarnadóttir I; Oldfors A; Nennesmo I; Holme E; Tulinius M; Darin N
    Eur J Paediatr Neurol; 2012 Jul; 16(4):379-89. PubMed ID: 22237560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymerase gamma deficiency (POLG): clinical course in a child with a two stage evolution from infantile myocerebrohepatopathy spectrum to an Alpers syndrome and neuropathological findings of Leigh's encephalopathy.
    Scalais E; Francois B; Schlesser P; Stevens R; Nuttin C; Martin JJ; Van Coster R; Seneca S; Roels F; Van Goethem G; Löfgren A; De Meirleir L
    Eur J Paediatr Neurol; 2012 Sep; 16(5):542-8. PubMed ID: 22342071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mono-allelic POLG expression resulting from nonsense-mediated decay and alternative splicing in a patient with Alpers syndrome.
    Chan SS; Longley MJ; Naviaux RK; Copeland WC
    DNA Repair (Amst); 2005 Dec; 4(12):1381-9. PubMed ID: 16181814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial DNA polymerase gamma is essential for mammalian embryogenesis.
    Hance N; Ekstrand MI; Trifunovic A
    Hum Mol Genet; 2005 Jul; 14(13):1775-83. PubMed ID: 15888483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. POLG exon 22 skipping induced by different mechanisms in two unrelated cases of Alpers syndrome.
    Mousson de Camaret B; Chassagne M; Mayençon M; Padet S; Crehalet H; Clerc-Renaud P; Rouvet I; Zabot MT; Rivier F; Sarda P; des Portes V; Bozon D
    Mitochondrion; 2011 Jan; 11(1):223-7. PubMed ID: 20691285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.